• TheverylatestonAlzheimertherapy• Theverytopleadersintheworld• Theverybestopportunitytolearnandinteractin awelcomingscientificenvironment

Formoreinformation,visitwww.ad-springfield.com

AQuarterCenturyofExcellenceWhereScienceandClinicalKnowledgeMeet

Photo © iStockPhoto.com

Advances in Alzheimer Therapy

ATA

14thInternationalAthens/SpringfieldSymposiumonAdvancesinAlzheimerTherapy

Athens,GreeceMarch9—12,2016

AQuarterCenturyofExcellenceWhereScienceandClinicalKnowledgeMeet

Leading clinicians and scientists will discuss new targets and drugs for the treatment of Alzheimer’s disease and novel approaches to current therapy. An oral communication session will be open to young scientists.

We expect approximately 1000 participants, mostly neurologists, psychiatrists, geriatricians and pharmacologists.

Topics:• Drug Discovery and Treatment Development• New Preclinical Models of Alzheimer’s Disease• Clinical Trials on Alzheimer’s Disease: New Designs and Measures• Early Diagnosis of Alzheimer’s Disease• Advances in Brain Imaging and Biomarkers• Novel PET Markers for Diagnosis and Drug Evaluation• Emerging Novel Therapeutic Targets• Preventive Trials of Alzheimer’s Disease• What is New in Immunization?• Tau Pathology and Tau-Focused Therapy: What’s New?

Athens,GreeceMarch9–12,2016

Organizers: Ezio Giacobini, Gabriel Gold and Sokratis G. PapageorgiouSponsors: SouthernIllinoisUniversitySchoolofMedicine,Springfield,Illinois,USA University of Geneva Medical School, Geneva, Switzerland Geneva University Hospitals, Department of Internal Medicine, Rehabilitation and Geriatrics, Geneva, Switzerland

Formoreinformation,visitwww.ad-springfield.com

Phot

o ©

iSto

ckPh

oto.

com

ATAdvances in Alzheimer Therapy

Geneva / Springfield

A